ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 29, 2005

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995

Impath Buys Clinical Studies Support Services Network.

September 28, 2001

December Business & Regulatory Report included in this issue.

December 12, 2003

In Brief: ACR to Move From Chicago To Washington D.C. Area; Hanks Astro President, Phillips President Elect

December 16, 1983